About Denteric
The Denteric Team are global experts in the field of Porphyromonas gingivalis (Pg) research and vaccine development, located in Australia and the US.
We are working on the development of safe, effective and convenient therapies that will successfully treat advanced periodontitis and other chronic inflammatory diseases.
Our ultimate goal is to provide a durable therapy that targets the cause not just the symptoms of inflammation related to gingipains.
Our Therapies
Denteric is developing therapies designed to inhibit and clear up the microbial toxins that cause periodontal disease (periodontitis).
Our therapies aim to reduce the inflammation and bleeding that contribute to tooth loss by preventing the tissue destruction caused by Pg.
Common symptoms associated with periodontal disease include bleeding or swollen gums, tooth sensitivity, loose teeth, and bad breath. Always seek advice from a healthcare professional such as a dentist or periodontist.
![]()
What will Denteric’s therapies do?
GPV381 is designed to stimulate durable antibodies that neutralise the gingipain toxins that cause chronic inflammation in periodontitis and other diseases. By treating the cause of disease, GPV381 breaks the chronic inflammatory cycle.
Our therapy is administered by injection in the arm at the same time as standard of care. It aims to restore immune control, leading to resolution of disease, healing of pockets, and providing a lasting benefit for patients.
Join a Clinical Trial
If you would like to learn more about our safety study in healthy volunteers or would like to participate in the upcoming Phase II study in patients with periodontitis, please contact us via the form at the bottom of the page.
Our Investors
We are headquartered in Melbourne Australia and supported by investment from:
Denteric People
Our team is filled with globally recognised experts in the field of Porphyromonas gingivalis research and immunotherapy development. Learn more about the people who are on a mission to develop the therapies that make severe periodontal disease a thing of the past.